Status:
UNKNOWN
Telemedicine in Outpatient Covid-19 Patients
Lead Sponsor:
Ludwig-Maximilians - University of Munich
Collaborating Sponsors:
Gesundheitsreferat (GSR), Landeshauptstadt München
Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Conditions:
Covid-19
Cardiovascular Risk Factor
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Covid-19, a commonly severe respiratory tract infection caused by the SARS-CoV2 Coronavirus, poses an increasing threat to individual health and health care systems. The individual disease course rang...
Eligibility Criteria
Inclusion
- Confirmed SARS-CoV2 infection and clinical Covid-19 disease
- age ≥18 years
- Presence of ≥1 relevan cardiovascular condition, defined as (or):
- atrial fibrillation
- systolic or diastolic heart failure
- LV ejection fraction \<50%
- coronary artery disease with past PCI or CABG
- Past myocardial infarction
- diabetes mellitus
- arterial hypertension (treated or untreated)
- active smoking
- chronic obstructive lung disease
- obesity (BMI ≥30kg/m2)
- availability of smartphone and sufficient internet connectivity at home
- ability to use smartwatch
- informed consent to study participation and data protection concept
Exclusion
- Participation in concurrent clinical trial
- indication for hospitalization at study entry
Key Trial Info
Start Date :
September 18 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
607 Patients enrolled
Trial Details
Trial ID
NCT04471636
Start Date
September 18 2020
End Date
June 30 2023
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LMU Klinikum
Munich, Bavaria, Germany, 81377